Decreased paraoxonase activity in critically ill patients with sepsis

Clinical and Experimental Medicine

Volumn 10, Issue 1, 2010, Pages 21-25

  Novak, Frantisek ^a,b,c   Vavrova, Lucie ^a   Kodydkova, Jana ^a   Hynkova, Magdalena ^a,b   Zak, Ales ^a   Novakova, Olga ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Cardiovascular Research Center   (Czech Republic)

Author keywords

C reactive protein; Critical care; High density lipoprotein; Paraoxonase 1; Sepsis

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; INTENSIVE CARE UNIT; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SEPSIS;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; SEPSIS;

EID: 75049086074     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0059-8     Document Type: Article

References (21)

1. RA Balk 2000 Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations Crit Care Clin 16 179 192 10.1016/S0749-0704(05) 70106-8 1:STN:280:DC%2BD3c3jtVKgsg%3D%3D 10768078
2. PS Martins EG Kallas MC Neto MA Dalboni S Blecher R Salomao 2003 Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock Shock 20 208 212 10.1097/01.shk.0000079425.52617.db 1:CAS:528: DC%2BD2cXjtFGksrc%3D 12923490
3. C Alvarez A Ramos 1986 Lipids, lipoproteins, and apoproteins in serum during infection Clin Chem 32 142 145 1:STN:280:DyaL28%2FnvF2qsQ%3D%3D 3940695
4. HJ van Leeuwen EC Heezius GM Dallinga JA van Strijp J Verhoef KP van Kessel 2003 Lipoprotein metabolism in patients with severe sepsis Crit Care Med 31 1359 1366 10.1097/01.CCM.0000059724.08290.51 12771603 (Pubitemid 36583844)
5. RW James SP Deakin 2004 The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity Free Radic Biol Med 37 1986 1994 10.1016/j.freeradbiomed.2004.08.012 1:CAS:528:DC%2BD2cXpslyju7Y%3D 15544917 (Pubitemid 39491318)
6. AD Watson JA Berliner SY Hama BN La Du KF Faull AM Fogelman M Navab 1995 Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 2882 2891 10.1172/JCI118359 1:CAS:528:DyaK28XmtVensw%3D%3D 8675659
7. A Wu CJ Hinds C Thiemermann 2004 High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications Shock 21 210 221 10.1097/01.shk.0000111661.09279.82 14770033
8. J McElveen MI Mackness CM Colley T Peard S Warner CH Walker 1986 Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction Clin Chem 32 671 673 1:STN:280:DyaL287mt1Witg%3D%3D 3006944
9. A Chait CY Han JF Oram JW Heinecke 2005 Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res 46 389 403 10.1194/jlr.R400017-JLR200 1:CAS:528:DC%2BD2MXit1SlsLw%3D 15722558 (Pubitemid 43109774)
10. B Mackness D Hine P McElduff M Mackness 2006 High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease Atherosclerosis 186 396 401 10.1016/j.atherosclerosis.2005.07.028 1:CAS:528:DC%2BD28Xks1Wkurc%3D 16140307
11. M Dirican R Akca E Sarandol K Dilek 2004 Serum paraoxonase activity in uremic predialysis and hemodialysis patients J Nephrol 17 813 818 1:CAS:528:DC%2BD2MXht1yqsL0%3D 15593056
12. D Boehm M Krzystek-Korpacka K Neubauer M Matusiewicz I Berdowska B Zielinski L Paradowski A Gamian 2009 Paraoxonase-1 status in Crohn's disease and ulcerative colitis Inflamm Bowel Dis 15 93 99 10.1002/ibd.20582 18626964
13. Y Kumon Y Nakauchi K Kidawara M Fukushima S Kobayashi Y Ikeda T Suehiro K Hashimoto JD Sipe 1998 A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response Scand J Immunol 48 419 424 10.1046/j.1365-3083.1998. 00416.x 1:CAS:528:DyaK1cXntFCktr0%3D 9790313 (Pubitemid 28459660)
14. M Aslan Y Nazligul M Horoz C Bolukbas FF Bolukbas M Gur H Celik O Erel 2008 Serum paraoxonase-1 activity in Helicobacter pylori infected subjects Atherosclerosis 196 270 274 10.1016/j.atherosclerosis.2006.10.024 1:CAS:528:DC%2BD1cXpt12jsw%3D%3D 17125774
15. KR Feingold RA Memon AH Moser C Grunfeld 1998 Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response Atherosclerosis 139 307 315 10.1016/S0021-9150(98)00084-7 1:CAS:528: DyaK1cXkt1yitbo%3D 9712337 (Pubitemid 28361815)
16. RC Bone RA Balk FB Cerra RP Dellinger AM Fein WA Knaus RM Schein WJ Sibbald 1992 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1644 1655 10.1378/chest.101.6.1644 1:STN:280: DyaK383ovFeiuw%3D%3D 1303622
17. WA Knaus EA Draper DP Wagner JE Zimmerman 1985 APACHE II: a severity of disease classification system Crit Care Med 13 818 829 10.1097/00003246- 198510000-00009 1:STN:280:DyaL2M3otlyqtQ%3D%3D 3928249
18. HW Eckerson CM Wyte BN La Du 1983 The human serum paraoxonase/ arylesterase polymorphism Am J Hum Genet 35 1126 1138 1:CAS:528: DyaL2cXjt1Kktg%3D%3D 6316781
19. BJ Van Lenten SY Hama FC de Beer DM Stafforini TM McIntyre SM Prescott BN La Du AM Fogelman M Navab 1995 Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J Clin Invest 96 2758 2767 10.1172/JCI118345 8675645
20. L Gaidukov DS Tawfik 2005 High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I Biochemistry 44 11843 11854 10.1021/bi050862i 1:CAS:528:DC%2BD2MXns1aitbk%3D 16128586 (Pubitemid 41262719)
21. U Ganter R Arcone C Toniatti G Morrone G Ciliberto 1989 Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6 EMBO J 8 3773 3779 1:CAS:528:DyaK3cXnsV2qtg%3D%3D 2555173